2Tolins JP,shooe BG,Raij L.Lnteractions.of hyperchvles-olemia and hypertension in imitiation of glomenlhur iujury[J].Kidney lnt,1992,41(5):1254-1261.
3Takahashi M,Arita Y,Yamagata K,et al,Genomic structure and mutations in adipose specific gene adiponectin[J].Int J Obes Relat Metab Disord,2000,24(7):861-868.
4Lee HS,Song CY.Oxidized lowdensity lipoprotein and oxidat ivestress in the development of glomeru loscleros[J].Am JN eph ro,2009,29:62-70.
5Bickel C,Rupprecht HJ,Blankenberg S,et al.Relation of markers of inflammation(C-reactive protein,fibrinogen,von Willebrandfactor,and leukocyte count)and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease[J].Am JCardiol,2002,89(8):901.
6Talwar S,Squire IB,Downie PF,et al.Plasma N terminal probrain natriuretic peptide and cardiotrophin1 are raised in unstable angina[J].Heart,2000,84(4):421.
7Krishnaswamy P,Lubien E,Clopton P,et al.Utitlity of Bnatriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction[J].Am J Med,2001,111(4):274.
